QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Olin Corporation (OLN)

Basic Materials

No action
Fundamental
2
Sentiment
3
Technical
3

Do Nothing: fundamentalScore is 2 (below the required floor of 3); the strategy requires fundamentalScore ≥ 3 before any bullish entry, so no trade plan was constructed despite a chart score of 3.

Analysis as of 2026-11-06· more than 2 trading days ago

Company overview

Olin Corporation is a global producer of chemical products, operating through three segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The company supplies industrial chemicals, epoxy materials, and ammunition products to various markets worldwide.

Fundamental

weak
Fundamental2
Leveraged cyclical risk

Olin shows cash generation but faces high leverage and credit risk, with a significant merger overhang.

Trough-cycle, leveraged chemicals producer: cash-generative but GAAP loss-making, with net leverage near 7x, sub-investment-grade ratings, a covenant-relief credit amendment and a transformative all-stock Huntsman merger due to close in the first quarter of 2027; cheap on trough multiples but not compelling for a short-horizon entry.

Sentiment

fair
Sentiment3
Mixed / forming

Sentiment is mixed with no strong retail or media momentum, and conflicting catalyst signals.

Two live positives carry the near-term setup — the regulator-confirmed EPA NESHAP amendments giving Olin regulatory certainty for new U.S. PVC manufacturing (2026-11-05, scored net-positive on every in-window item) and the all-stock Huntsman merger of equals tracking toward a Q1 2027 close — set against a soft-but-mixed Q3 print (adjusted EPS beat, revenue miss on chemical weakness, as-reported EPS down ~65% y/y, Q4 adjusted EBITDA guided to $80–100M) and modest post-print analyst target cuts. The media delta is determinate and mildly negative (baseline polarity_score ≈ +0.14 cooling to ≈ 0.00 in the 14-day window) and a moderate red-flag cap applies for conflicting catalyst signals, while the severe screen is clear — no regulator-confirmed fraud/accounting/bribery investigation, no going-concern language, and the October 2026 financing is a maturity-lengthening refinancing rather than a distress raise.

Technical

fair
Technical3
Mixed-to-constructive

The chart shows a short-term recovery uptrend but remains below long-term resistance levels.

Chart quality is mixed-to-constructive, not a clean trend. Price 17.435 sits above the SMA20 (16.21), SMA50 (16.46), EMA9 (17.29) and EMA21 (16.70), MACD is positive and expanding (line 0.44 > signal 0.16 > 0, histogram +0.28) and ADX14 is 26.82 and rising from 21.62 on 2026-10-29 — a genuine short/intermediate uptrend off the 14.64 low. Against that: price is 21.4% below a falling SMA200 (22.19) and below the DEMA14 (17.65), TEMA14 (18.12) and daily VWAP (17.60); RSI14 has cooled from 68.16 to 57.41; and the latest session gave back ~3.5% on the largest single-session volume of the last three sessions, so short-term thrust is stalling. ATR14 0.77 is 4.45% of price and liquidity is ample (~$67.4M 20-day average, ~$64.6M over the last three completed sessions). Score 3 — real bullish evidence on the short/medium frame offset by a longer-term downtrend and a stalling last session. No trade plan was constructed: fundamentalScore 2 is below the required floor of 3, a hard block that suppresses the action regardless of chart quality.

You’re looking at 2026-11-06 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.